Modulation of striatal cholinergic interneuron activity to prevent dystonic cerebral palsy
调节纹状体胆碱能中间神经元活动以预防肌张力障碍性脑瘫
基本信息
- 批准号:10636773
- 负责人:
- 金额:$ 18.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:ARHGEF5 geneAddressAdultAffectAgonistAnimalsAnti-CholinergicsAwardBasal GangliaBrainCerebral PalsyChildChildhoodCholinergic AgentsChronicClinicalClozapineCorpus striatum structureDataDopamineDopamine D2 ReceptorDystoniaElectrophysiology (science)EnsureEnvironmentExhibitsFacultyFunctional disorderGeneticGoalsGrantHypoxiaHypoxic Brain DamageImplantIn VitroInjectionsInjuryInstitutionInterneuronsInterventionIschemiaJordanLifeLigandsLive BirthMeasuresMediatingMedicalMentorsMentorshipModelingMotorMusNeonatalNeonatal Brain InjuryNeurologyNeuronsOxidesPathologyPharmaceutical PreparationsPhysiciansPregnancyPreventionPreventive treatmentRefractoryResearchResearch PersonnelRodent ModelRunningScientific Advances and AccomplishmentsScientistSeveritiesSliceTestingTherapeuticTrainingTranslational ResearchUniversitiesViralVisualWashingtoncareercholinergicclinically relevantdesigner receptors exclusively activated by designer drugsdisabilityexperimental studyfluhypoxia neonatorumin vivoinnovationmedical schoolsmouse modelmultidisciplinarypediatric dystoniapostnatalpresymptomatic testingpreventresponsetherapeutic targettherapy development
项目摘要
PROJECT SUMMARY
This proposal will determine whether increasing striatal cholinergic interneuron (ChI) activity in the developing
mouse brain can prevent dystonia following neonatal brain injury
. Dystonic cerebral palsy (CP) due to neonatal
brain injury is the most common cause of childhood dystonia and is often medically refractory and functionally
debilitating. Yet, its unique pathophysiology remains understudied. Dystonia pathophysiology is more commonly
studied in models of rare genetic dystonias which are characterized by striatal ChI hyperexcitability. However,
anticholinergic medications are often ineffective for treating dystonia in CP. Determining whether there is striatal
cholinergic pathology specific to dystonic CP could yield better targeted treatments. To this end, I have developed
a clinically-relevant rodent model of neonatal hypoxic brain injury that displays electrophysiologic markers of
dystonia three weeks after injury, mimicking the clinical latency period between neonatal brain injury and dystonia
emergence. This latency period allows testing of pre-symptomatic interventions for dystonia prevention. My
preliminary data demonstrate increased striatal ChI number in my model but that striatal ChI excitation in young
mice during the pre-symptomatic window may be protective against dystonia. In sum, these data suggest that
increased striatal ChI number and striatal ChI hyperexcitability may be compensatory mechanisms that are
protective against dystonia and, therefore, could be enhanced to prevent dystonia following neonatal brain injury.
To test this hypothesis, I propose the following aims: (1) determine whether chemogenetic modulation of striatal
ChI activity in young mice after neonatal brain injury changes dystonia severity in adult mice; (2) determine
whether chemogenetic modulation of striatal ChI activity in young, otherwise healthy, mice can cause dystonia
in adult mice; and (3) determine whether the striatal ChI hyperexcitability observed in genetic dystonias is also
present in my model of dystonia following neonatal brain injury. These studies will determine whether pre-
symptomatically increasing striatal ChI firing after neonatal brain injury could reduce or prevent dystonia.
My long-term career goal is to run a translational research lab focused on preventative treatment development
for dystonic CP. I have studied basal ganglia pathophysiology for ten years and have developed a new model of
dystonia following neonatal brain injury which will be used for the proposed experiments. However, to complete
the proposed research and facilitate my transition to independence, I need additional mentored training in slice
electrophysiology (Dr. Steve Mennerick) and chemogenetics (Dr. Jordan McCall). As my physician-scientist
advisor, Dr. Joel Perlmutter will provide expertise in dystonia pathophysiology and ensure the translational
relevance of my research. The Washington University School of Medicine and Department of Neurology provide
a world-renowned research environment and a legacy of passionately and effectively supporting junior faculty.
In sum, my proposed research, mentorship team, training plan, and institutional environment pave my path to
independence and submission of an R01 on
identification of treatment targets
for dystonic CP.
项目总结
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The Role of Child Neurologists in the Management of Motor Disability in Cerebral Palsy: Establishing the Path Forward.
儿童神经科医生在脑瘫运动障碍管理中的作用:建立前进的道路。
- DOI:10.1016/j.pediatrneurol.2023.03.018
- 发表时间:2023
- 期刊:
- 影响因子:3.8
- 作者:Gelineau-Morel,Rose;Kim,Young-Min;O'Malley,JenniferA;Wilson,JennyL;Aravamuthan,BhoomaR
- 通讯作者:Aravamuthan,BhoomaR
Uncertainties regarding cerebral palsy diagnosis: opportunities to operationalize the consensus definition.
脑瘫诊断的不确定性:实施共识定义的机会。
- DOI:10.1101/2023.06.29.23292028
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Aravamuthan,BhoomaR;Fehlings,DarcyL;Novak,Iona;Gross,Paul;Alyasiri,Noor;Tilton,Ann;Shevell,Michael;Fahey,Michael;Kruer,Michael
- 通讯作者:Kruer,Michael
Cerebral Palsy in Child Neurology and Neurodevelopmental Disabilities Training: An Unmet Need.
- DOI:10.1177/08830738211072711
- 发表时间:2022-03
- 期刊:
- 影响因子:1.9
- 作者:
- 通讯作者:
A Broader Perspective on Motor Rehabilitation Guidelines for Cerebral Palsy.
脑瘫运动康复指南的更广泛视角。
- DOI:10.1212/wnl.0000000000201048
- 发表时间:2022
- 期刊:
- 影响因子:9.9
- 作者:Tilton,AnnHenderson;Coffman,Keith;Aravamuthan,BhoomaR
- 通讯作者:Aravamuthan,BhoomaR
Mice born preterm develop gait dystonia and reduced cortical parvalbumin immunoreactivity.
早产小鼠出现步态肌张力障碍并降低皮质小白蛋白免疫反应性。
- DOI:10.1101/2024.02.01.578353
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Gemperli,Kat;Folorunso,Femi;Norin,Benjamin;Joshua,Rebecca;Hill,Clayton;Rykowski,Rachel;Galindo,Rafael;Aravamuthan,BhoomaR
- 通讯作者:Aravamuthan,BhoomaR
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BHOOMA ARAVAMUTHAN其他文献
BHOOMA ARAVAMUTHAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BHOOMA ARAVAMUTHAN', 18)}}的其他基金
Modulation of striatal cholinergic interneuron activity to prevent dystonic cerebral palsy
调节纹状体胆碱能中间神经元活动以预防肌张力障碍性脑瘫
- 批准号:
10353430 - 财政年份:2021
- 资助金额:
$ 18.64万 - 项目类别:
Modulation of striatal cholinergic interneuron activity to prevent dystonic cerebral palsy
调节纹状体胆碱能中间神经元活动以预防肌张力障碍性脑瘫
- 批准号:
10215974 - 财政年份:2021
- 资助金额:
$ 18.64万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 18.64万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 18.64万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 18.64万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 18.64万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 18.64万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 18.64万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 18.64万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 18.64万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 18.64万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 18.64万 - 项目类别:
Research Grant